← All companies
LIAN
LianMedical
$0.05
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$5.14M
Revenue (TTM)
—
Net income (TTM)
-$88.0M
EPS (TTM)
$-0.81
P/E ratio
—
Dividend yield
—
Free cash flow
-$101M
Cash
$103M
Total assets
$263M
Gross margin
—
52-week range
$0.05 – $0.18
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Exit or disposal costs; Delisting notice or listing-rule failure; Regulation FD disclosure; Other events
Feb 13, 2024
8-K
Entered a material agreement; Terminated a material agreement
Dec 26, 2023
8-K
Director or officer change; Regulation FD disclosure
Dec 20, 2023
8-K
Director or officer change; Regulation FD disclosure
Dec 19, 2023
8-K
Regulation FD disclosure
Dec 6, 2023
8-K
Other events
Dec 1, 2023
10-Q
Quarter ended 2023-09-30
Nov 13, 2023
8-K
Results of operations (earnings release)
Nov 13, 2023
8-K
Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Regulation FD disclosure
Oct 30, 2023
10-Q
Quarter ended 2023-06-30
Aug 14, 2023
8-K
Results of operations (earnings release)
Aug 14, 2023
8-K
Shareholder vote results
Jun 23, 2023
10-Q
Quarter ended 2023-03-31
May 11, 2023
8-K
Results of operations (earnings release)
May 11, 2023
8-K
Regulation FD disclosure
May 1, 2023
8-K
Regulation FD disclosure; Other events
Apr 26, 2023
8-K
Other events
Apr 21, 2023
10-K
Fiscal year ended 2022-12-31
Mar 28, 2023
8-K
Results of operations (earnings release)
Mar 27, 2023
8-K
Director or officer change
Mar 17, 2023
8-K
Entered a material agreement; Regulation FD disclosure
Dec 19, 2022
8-K
Director or officer change
Dec 13, 2022
10-Q
Quarter ended 2022-09-30
Nov 10, 2022
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 10, 2022
8-K
Other events
Oct 12, 2022
10-Q
Quarter ended 2022-06-30
Aug 11, 2022
8-K
Results of operations (earnings release)
Aug 11, 2022
8-K
Shareholder vote results
Jun 10, 2022
10-Q
Quarter ended 2022-03-31
May 12, 2022
8-K
Results of operations (earnings release); Regulation FD disclosure
May 12, 2022
8-K
Director or officer change
Apr 8, 2022
10-K
Fiscal year ended 2021-12-31
Mar 31, 2022
8-K
Results of operations (earnings release)
Mar 30, 2022
8-K
Regulation FD disclosure
Mar 2, 2022
10-Q/A
Quarter ended 2021-09-30
Jan 10, 2022
10-Q
Quarter ended 2021-09-30
Dec 9, 2021
8-K
Results of operations (earnings release)
Dec 9, 2021
8-K
Entered a material agreement; Took on a direct financial obligation
Nov 10, 2021
8-K
Amended charter or bylaws
Nov 3, 2021
Other filings
SC 13G
Nov 14, 2024